TU Dresden is a public research university, the largest institute of higher education in the city of Dresden, the largest university in Saxony and one of the 10 largest universities in Germany with 32,389 students as of 2018.

During the past decade, Technische Universität Dresden conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 4 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Technische Universität Dresden" #1 sponsor was "Technische Universität Dresden" with 10 trials, followed by "Mallinckrodt" with 2 trials sponsored, "United Therapeutics" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored and "Arog Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Technische Universität Dresden" #1 collaborator was "Charite University, Berlin, Germany" with 3 trials as a collaborator, "Boston University" with 2 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator and "University Hospital Carl Gustav Carus" with 2 trials as a collaborator. Other collaborators include 37 different institutions and companies that were collaborators in the rest 46 trials.

According to Clinical.Site data, the most researched conditions in "Technische Universität Dresden" are "Anxiety Disorders" (2 trials), "Atrial Fibrillation" (2 trials), "Breast Cancer" (2 trials), "Coronary Artery Disease" (2 trials) and "Ovarian Cancer" (2 trials). Many other conditions were trialed in "Technische Universität Dresden" in a lesser frequency.

Most popular intervention types in "Technische Universität Dresden" are "Drug" (24 trials), "Device" (7 trials), "Other" (7 trials), "Procedure" (7 trials) and "Behavioral" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "G-CSF" (2 trials), "ACURATE TA™ Transapical Aortic Bioprosthesis" (1 trials), "Amine fluoride" (1 trials) and "Applied Relaxation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Technische Universität Dresden" are 36 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Technische Universität Dresden". 1 are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Technische Universität Dresden, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Technische Universität Dresden, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 9 trials that are defined as “Not Applicable".